Kodak’s stock skyrocketed severalfold today, and it had nothing to do with the company’s long-established business in the world of photography. News broke that Kodak had secured at $765 million loan from the US government to shift its attention to producing ingredients for generic drugs.
The Wall Street Journal reports that Kodak received the first […]. petapixel.com
Earlier this summer, Adobe made some sweeping changes to Adobe Stock, primarily aimed at protecting real artists from AI-generated harm on the platform. PetaPixel got a preview of some other new features, which have now arrived to Stock. [Read More]
Since Adobe released its text-to-image generative AI tool, Firefly, last year, the company had to grapple with diverse new challenges. Adobe Stock, perhaps as much as any of Adobe's platforms, had to adapt quickly. [Read More]
After over half a century as a privately-held business, the Swedish lighting company Profoto went public today, listing its shares on the Nasdaq Stockholm stock exchange. As a public company, Profoto is now required to publicly disclose its financial performance for the first time.
Here are our top tips for incorporating the resurgence of all things hygge into your Licensing portfolio—while creating seasonal stock photos that sell. The post How to capture hygge in commercial photography appeared first on 500px.
Kodak’s stock price has gone on quite a roller coaster ride over the past week after the company announced a $765M US loan to pivot into generic drug production. But it’s not just the price people are talking about — unusual trading activity and a stock option grant to Kodak’s CEO are also making headlines. […]
Activist investor Daniel Loeb is reportedly using the current low stock prices to build a bigger stake in Sony and “push for changes,” including spinning off the brand’s image sensor business into a separate entity called Sony Technologies.